Transcriptomics, single-cell sequencing and spatial sequencing-based studies of cerebral ischemia

Area of Science:

• Neuroscience
• Genomics
• Molecular Biology

Background:

• Cerebral ischemia presents high morbidity, mortality, and recurrence rates due to complex pathogenesis.
• Understanding the intricate molecular mechanisms is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To review research progress on cerebral ischemic injury mechanisms.
• To explore the utility of comprehensive transcriptomics in identifying novel therapeutic targets and biomarkers for cerebral ischemia.

Main Methods:

• Integration of multi-level transcriptomic data, including transcriptomics, single-cell transcriptomics, and spatial transcriptomics.
• Analysis of molecular pathways involved in the occurrence and development of cerebral ischemia.

Main Results:

• Highlighted critical roles of inflammation, blood-brain barrier dysfunction, and mitochondrial dysregulation in cerebral ischemia.
• Identified potential biomarkers for early diagnosis and therapeutic targets for personalized treatment.

Conclusions:

• Comprehensive transcriptomics provides powerful insights into the molecular mechanisms of cerebral ischemia.
• This approach facilitates the discovery of innovative therapeutic strategies for cerebral ischemia.